TEVA PHARMACEUTICAL INDUSTRIES LIMITED Advertising Expense
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Advertising Expense of $309.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED advertising expense for fiscal 2025 was $309.00M, a 19.31% increase from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED advertising expense for fiscal 2024 was $259.00M, a 59.88% increase from fiscal 2023.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED advertising expense for fiscal 2023 was $162.00M, a 3.57% decline from fiscal 2022.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED advertising expense for fiscal 2022 was $168.00M, a 31.71% decline from fiscal 2021.
| Period end | Advertising Expense 12 month |
|---|---|
| 2025-12-31 | $309.00M 10-K · filed 2026-02-03 |
| 2024-12-31 | $259.00M 10-K · filed 2026-02-03 |
| 2023-12-31 | $162.00M 10-K · filed 2026-02-03 |
| 2022-12-31 | $168.00M 10-K · filed 2025-02-05 |
| 2021-12-31 | $246.00M 10-K · filed 2024-02-12 |
| 2020-12-31 | $225.00M 10-K · filed 2023-02-10 |
| 2019-12-31 | $213.00M 10-K · filed 2022-02-09 |
| 2018-12-31 | $256.00M 10-K · filed 2021-02-10 |
| 2017-12-31 | $318.00M 10-K · filed 2020-02-21 |
| 2016-12-31 | $312.00M 10-K · filed 2019-02-19 |
| 2015-12-31 | $297.00M 10-K · filed 2018-02-12 |
| 2014-12-31 | $302.00M 20-F · filed 2017-02-15 |
| 2013-12-31 | $321.00M 20-F · filed 2016-02-11 |
| 2012-12-31 | $337.00M 20-F · filed 2015-02-09 |
| 2011-12-31 | $248.00M 20-F · filed 2014-02-10 |
| 2010-12-31 | $243.00M 20-F · filed 2013-02-12 |
| 2009-12-31 | $212.00M 20-F · filed 2012-02-17 |
| 2008-12-31 | $87.00M 20-F · filed 2011-02-15 |